Get the Stockscreener App
3.00
0.33%
0.010
Calcimedica Inc stock is traded at $3.00, with a volume of 4,030.
It is up +0.33% in the last 24 hours and down -2.46% over the past month.
CalciMedica Inc is a clinical-stage biopharmaceutical company focused on developing therapeutics that treat serious illnesses driven by inflammatory and immunologic processes and direct cellular damage. Its product candidates act upon calcium release-activated calcium (CRAC) channels and would constitute a new class of drugs. Its product candidate is Auxora, a potent and selective intravenous formulated small molecule CRAC channel inhibitor containing the active compound zegocractin (formerly referred to as CM4620) that, in animal models, reduced acute epithelial and/or endothelial cell injury and inflammation in organs, such as the pancreas, lungs and kidneys.
See More
Previous Close:
$2.99
Open:
$3.03
24h Volume:
4,030
Relative Volume:
0.07
Market Cap:
$41.71M
Revenue:
-
Net Income/Loss:
$-20.87M
P/E Ratio:
-1.8839
EPS:
-1.5924
Net Cash Flow:
$-21.21M
1W Performance:
-0.20%
1M Performance:
-2.46%
6M Performance:
+91.08%
1Y Performance:
-18.92%
1-Day Range:
$2.97
$3.03
1-Week Range:
$2.96
$3.14
52-Week Range:
$1.42
$4.22
Calcimedica Inc Stock (CALC) Company Profile
Name
Calcimedica Inc
Sector
Industry
Phone
858-952-5500
Address
505 COAST BOULEVARD SOUTH, LA JOLLA
Compare CALC with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CALC
Calcimedica Inc
|
2.985 | 41.78M | 0 | -20.87M | -21.21M | -1.5924 |
|
VRTX
Vertex Pharmaceuticals Inc
|
422.76 | 107.66B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
655.00 | 68.74B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
451.91 | 58.93B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
ARGX
Argen X Se Adr
|
813.02 | 50.51B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
190.00 | 41.29B | 398.11M | -1.03B | -868.57M | -5.7032 |
Calcimedica Inc Stock (CALC) Latest News
Can CalciMedica Inc. recover in the next quarter2025 Key Lessons & Risk Controlled Stock Alerts - newser.com
Analyzing net buyer seller activity in CalciMedica Inc.2025 Institutional Moves & Consistent Profit Trade Alerts - newser.com
Regression analysis insights on CalciMedica Inc. performanceJuly 2025 Catalysts & Safe Entry Momentum Stock Tips - newser.com
Is CalciMedica Inc. stock near bottom after declinePortfolio Performance Report & Advanced Swing Trade Entry Alerts - newser.com
Best data tools to analyze CalciMedica Inc. stockMarket Sentiment Summary & Smart Investment Allocation Tips - newser.com
Is CalciMedica Inc. stock reversal real or fake2025 Trade Ideas & Real-Time Stock Movement Alerts - newser.com
Should I hold or sell CalciMedica Inc. stock in 2025July 2025 Review & Weekly Breakout Watchlists - newser.com
Is CalciMedica Inc. stock bottoming outProfit Target & AI Enhanced Trading Alerts - newser.com
Using data filters to optimize entry into CalciMedica Inc.Bond Market & Real-Time Stock Entry Alerts - newser.com
What MACD and RSI say about CalciMedica Inc.July 2025 Breakouts & Reliable Volume Spike Alerts - newser.com
Analyzing CalciMedica Inc. with risk reward ratio chartsQuarterly Market Summary & Reliable Price Action Trade Plans - newser.com
Technical signs of recovery in CalciMedica Inc.July 2025 Catalysts & Fast Gaining Stock Strategy Reports - newser.com
Detecting support and resistance levels for CalciMedica Inc.Weekly Trend Report & AI Forecasted Stock Moves - newser.com
Analyzing drawdowns of CalciMedica Inc. with statistical toolsEarnings Summary Report & Long-Term Capital Growth Ideas - newser.com
Published on: 2025-10-29 06:14:19 - newser.com
Is CalciMedica Inc. still worth holding after the dip2025 Macro Impact & Free Safe Entry Trade Signal Reports - newser.com
Published on: 2025-10-29 04:44:07 - newser.com
How to build a custom watchlist for CalciMedica Inc.Trade Ideas & AI Powered Market Entry Ideas - newser.com
Custom strategy builders for tracking CalciMedica Inc.Trade Exit Summary & Real-Time Market Sentiment Reports - newser.com
Comparing CalciMedica Inc. in custom built stock radarsTrade Risk Report & Fast Exit/Entry Strategy Plans - newser.com
CalciMedica Inc Stock Analysis and ForecastEconomic Indicators Overview & Superior Wealth Strategies - earlytimes.in
Is CalciMedica Inc. stock a safe haven assetPortfolio Return Report & Daily Profit Maximizing Tips - Fundação Cultural do Pará
What recovery options are there for CalciMedica Inc.Exit Point & Expert Approved Momentum Ideas - newser.com
Calcimedica’s Auxora Study: A Potential Game-Changer for AKI Treatment - TipRanks
Calcimedica Inc Stock (CALC) Financials Data
Revenue
Net Income
Cash Flow
EPS
Calcimedica Inc Stock (CALC) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Roberts Eric W | CHIEF BUSINESS OFFICER |
Sep 15 '25 |
Buy |
2.68 |
3,400 |
9,105 |
81,650 |
| Roberts Eric W | CHIEF BUSINESS OFFICER |
Sep 12 '25 |
Buy |
3.12 |
5,000 |
15,600 |
78,250 |
| Roberts Eric W | CHIEF BUSINESS OFFICER |
Sep 09 '25 |
Buy |
3.15 |
2,343 |
7,378 |
73,250 |
| Roberts Eric W | CHIEF BUSINESS OFFICER |
Aug 28 '25 |
Buy |
2.86 |
9,200 |
26,340 |
70,107 |
| Roberts Eric W | CHIEF BUSINESS OFFICER |
Aug 29 '25 |
Buy |
2.74 |
800 |
2,192 |
70,907 |
| Roberts Eric W | CHIEF BUSINESS OFFICER |
Aug 21 '25 |
Buy |
2.79 |
3,508 |
9,797 |
60,907 |
| Roberts Eric W | CHIEF BUSINESS OFFICER |
Aug 20 '25 |
Option Exercise |
1.53 |
15,000 |
22,950 |
179,706 |
| Roberts Eric W | CHIEF BUSINESS OFFICER |
Aug 20 '25 |
Buy |
2.72 |
2,000 |
5,440 |
57,399 |
| Roberts Eric W | CHIEF BUSINESS OFFICER |
Aug 19 '25 |
Buy |
2.79 |
1,000 |
2,790 |
55,399 |
| Hebbar Sudarshan | Chief Medical Officer |
Aug 19 '25 |
Buy |
2.82 |
9,563 |
26,962 |
61,539 |
1.19%
0.89%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):